Molecule Details
| InChIKey | SQZJGTOZFRNWCX-UHFFFAOYSA-N |
|---|---|
| Compound Name | Elcubragistat |
| Canonical SMILES | O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccc(C(F)(F)F)cc2N2CCCC2)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.43 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB16036 |
|---|---|
| Drug Name | ABX-1431 |
| CAS Number | 1446817-84-0 |
| Groups | investigational |
| ATC Codes | nan |
| Description | ABX-1431 is under investigation in clinical trial NCT03625453 (Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder). |
Cross-references: BindingDB: 180052 CHEMBL3945728 ChemSpider: 61719539
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| Q99685 | MGLL | Monoglyceride lipase | inhibitor | targets |